Luxa to Present RPESC-RPE-4W Therapy Data at 2025 ARVO Meeting
29 Apr 2025 //
BUSINESSWIRE
Luxa Biotechnology Presents Clinical Data at Wills Eye Conference
06 Mar 2025 //
BUSINESSWIRE
Luxa Biotech’s RPESC-RPE-4W Gets FDA RMAT For Dry AMD Treatment
18 Feb 2025 //
BUSINESSWIRE
Luxa Biotechnology Appoints Keith E. Dionne As CEO
01 Oct 2024 //
BUSINESSWIRE